Specialist inspectors have identified cases of Salbutamol inhaler overprescribing of up to six inhalers per prescription by online prescribers. In this article, co-produced by our CPhO Clinical Fellow Aileen O’Hare and Toby Capstick, Consultant Pharmacist Respiratory Medicine, we explore the risks of prescribing high volumes of Salbutamol inhalers. We highlight the need for ongoing patient monitoring, counselling advice, inhaler device choices and discuss the clinical considerations when continuing treatment.

Clinical guidance

In this issue (June 2022)

31 May 2022
We have worked with the Food Standards Agency on this article which explains what you need to know about how cannabidiol products are regulated and what you must do if your pharmacy is selling a...
31 May 2022
Specialist inspectors have identified cases of Salbutamol inhaler overprescribing of up to six inhalers per prescription by online prescribers. In this article, co-produced by our CPhO Clinical...
31 May 2022
Help to make sure sodium valproate is dispensed safely to women and girls

A recent article in the BMJ (Sodium valproate continues to be prescribed in hundreds of pregnancies, data show) revealed...

31 May 2022
The next time you renew on or after 1 October 2022, you’ll need to complete a full revalidation submission: four CPD records, a peer discussion and a reflective account. Here’s a quick guide to what...
31 May 2022
Instead of pharmacists needing to be on the register for two years before applying for an independent prescriber course, applicants will need to have relevant experience in a pharmacy setting and be...